ABSTRACT: For the identification of the seven Nitrosamine Impurities i.e. N-Methyl-N-Nitrosopropane-1,3-diamine (Nitroso MAPA), N-Nitrosomethyl phenylamine (NMPA), N-Nitrosoethylisopropylamine (NEIPA) ...
Neurofibromatosis type 1 (NF1) is a genetic disorder characterized by the development of plexiform neurofibromas (PNs), benign yet potentially debilitating tumors with limited treatment options.
ABSTRACT: Purpose: This study aimed to evaluate the safety profile and clinical acceptance of FemPhylloTM, a novel ready-to-use base for mucoadhesive vaginal films, in the context of personalized ...
PHILADELPHIA, March 3, 2025 /PRNewswire/ -- TransCelerate BioPharma (TransCelerate), a global nonprofit organization dedicated to improving the health of patients by accelerating and simplifying the ...
Introduction Intracerebral haemorrhage (ICH) stands as a leading global cause of death and disability, posing a significant challenge with limited treatment options, especially for chronic patients.
ABU DHABI, UAE — In the past 9 months, a surge of new trials related to the management of intracranial hemorrhage (ICH) has led the European Stroke Organisation (ESO) to delay issuing a planned ...
Poster discussing what the ICH Q14 guidelines entail and how AutoChrom can help implement these principles. The poster includes details about the ICH Q14 guidelines and specific details about how ...
On March 7, 2024, the FDA adopted ICH Guideline Q14 Analytical Procedure Development, which became official on November 1, 2023. This guidance complements updated ICH Guideline Q2(R2) Validation of ...
PHILADELPHIA--(BUSINESS WIRE)--Instem, a leading provider of IT solutions and services to the global life sciences market, announced today that its latest in silico solution offering known as Advance™ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback